Roche Holding AG
SIX:ROG
Roche Holding AG
Cost of Revenue
Roche Holding AG
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Cost of Revenue
-CHf15.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-2%
|
|
Novartis AG
SIX:NOVN
|
Cost of Revenue
-$12B
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Cost of Revenue
-$4.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Cost of Revenue?
Cost of Revenue
-15.6B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Cost of Revenue amounts to -15.6B CHF.
What is Roche Holding AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-2%
Over the last year, the Cost of Revenue growth was 16%. The average annual Cost of Revenue growth rates for Roche Holding AG have been 1% over the past three years , 1% over the past five years , and -2% over the past ten years .